Training activity information
Details
Respond to clinical queries/ significant results related to the diagnosis and management of infection in patients with haematological malignancies and bone marrow transplants.
To include selection and interpretation of relevant tests and drafting of advice.
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What specific knowledge about common infections, diagnostic approaches, and prophylactic strategies in this population do you need to prepare?
- What specific understanding of the unique challenges in diagnosing and managing infections in severely immunocompromised patients do you hope to gain? What is your current understanding of the impact of their underlying conditions and treatments on infection risk?
- Have you discussed the specific types of queries and significant results common in this patient group with your training officer? What challenges might arise in interpreting results or advising on management? How will you approach these? What are your initial thoughts and feelings about this activity?
In action
- How are you initiating your response to the clinical query or significant result in this immunocompromised patient group?
- What is guiding your initial steps? What decisions are you making regarding the types of tests to consider and how to interpret potentially complex results in this context?
- How is this influencing your advice? What feels natural in your response, and where are you having to consciously apply specific knowledge related to haematological malignancies and transplant patients?
- How well do you believe your approach is addressing the diagnostic and management needs for this patient group?
- What specific challenges related to infection in patients with haematological malignancies and bone marrow transplants are you facing?
- What new insights are you gaining about managing infections in this vulnerable population as you proceed?
- How does this activity relate to your understanding of the interplay between the immune system, malignancy, transplantation, and infection?
- Are you considering different diagnostic or treatment pathways based on the information you are receiving?
- Are there areas where you feel less confident and might require immediate input from a supervisor or specialist?
- Are you operating within the established guidelines and your level of competence for this type of case?
On action
- Begin by summarising the key points of the experience of responding to clinical queries/significant results for patients with haematological malignancies and bone marrow transplants.
- What skills or knowledge did you develop or improve related to the selection and interpretation of relevant tests for this highly immunocompromised patient group?
- Were there any unexpected challenges or successes in drafting advice for managing infections in these complex cases?
- What did you learn from these? In what ways did your reflection-in-action (during the activity) influence how you considered the impact of their underlying condition on infection diagnosis and management?
- How does this experience relate to the requirements for post-programme practice in understanding the unique challenges of infection in patients with haematological malignancies and bone marrow transplants?
- What areas for continued development have been identified in responding to clinical queries for this specific patient group?
- How can you apply the learning from this activity to your routine practice when dealing with similar cases or when collaborating with haematology teams?
- Identify the actions / ‘next steps’ you will now take to support the assimilation of what you have learned, such as familiarising yourself with relevant guidelines or antifungal stewardship programmes
- What support or resources might you need to further develop your skills in this area, such as attending multidisciplinary team meetings or reviewing relevant literature?
Beyond action
- How has your understanding of managing infections in patients with haematological malignancies and bone marrow transplants evolved since undertaking this DTA and gaining further experience?
- How have you applied the skills and knowledge gained from this DTA regarding test selection, interpretation, and advice drafting for this patient group to other immunosuppressed patient scenarios?
- What connections can you draw between this DTA and other training activities or clinical experiences, such as attending relevant multidisciplinary team meetings, and how do they build towards your overall development as a Healthcare Scientist?
- What further development needs related to infections in haematological malignancies/BMT patients have been identified through revisiting this experience, and what actions will you now take?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Identify appropriate investigative strategies to diagnose and manage infections associated with specialist patient groups, considering guidance and public health requirements |
| # 2 |
Outcome
Select tests to diagnose and manage infections and interpret the results in the clinical context for specialist patient groups, with consideration of laboratory quality assurance and quality control |
| # 3 |
Outcome
Develop plans and provide advice on infection management for specialist patient groups considering infection control, guidelines and public health requirements |